>> Sunday
>> Monday
>> Tuesday
>> Wednesday
Tuesday 09 July 2024
08:30 - 09:30
Session 34: Live imaging of preimplantation embryos
Tuesday 09 July 2024
08:30 - 09:30: Session 34: Live imaging of preimplantation embryos:
M.H.E.C. Pieters, The Netherlands
08:30 - 08:50
Non-invasive evaluation of embryo metabolic activity through hyperspectral microscopy
09:00 - 09:20
Instructions for assembly of early mammalian embryos
Nicolas Plachta, Singapore Rep. of
08:30 - 09:30
Session 35: Fertility in transmasculine people
08:30 - 09:30: Session 35: Fertility in transmasculine people:
Caroline Roelens, Belgium
Taghride Dahhan, The Netherlands
08:30 - 08:50
Ovarian function in transmasculine people
09:00 - 09:20
Fertility in transmasculine people
Norah Van Mello, The Netherlands
08:30 - 09:30
Session 36: Novel technology and concepts for preimplantation and prenatal testing
08:30 - 09:30: Session 36: Novel technology and concepts for preimplantation and prenatal testing:
Francesco Fiorentino, Italy
Jitske Eliveld, The Netherlands
08:30 - 08:50
Advances in PGT diagnostics - technologies beyond copy number
Christian Simon Ottolini, United Kingdom
09:00 - 09:20
Advances in prenatal diagnosis for the follow-up of PGT pregnancies
Masoud Zamani Esteki, The Netherlands
08:30 - 09:30
Session 37: Channeling sperm motility
08:30 - 09:30: Session 37: Channeling sperm motility:
Astrid Cantineau, The Netherlands
08:30 - 08:50
Architecture and in situ arrangement of the CatSper-channel complex in the sperm flagellum
09:00 - 09:20
The role of CatSper in male infertility - from bench to bedsite and back
08:30 - 09:30
Session 38: European and Global ART Monitoring
08:30 - 09:30: Session 38: European and Global ART Monitoring:
Diane De Neubourg, Belgium
08:30 - 09:00
Assisted Reproductive Technology (ART) in Europe 2021 and development of a strategy of vigilance: Preliminary results generated from European registers by the ESHRE EIM Consortium
Jesper M.J. Smeenk, The Netherlands
09:00 - 09:15
ICMART Preliminary World Report 2020
09:15 - 09:30
Using real world data from ART registries in the health education of patients
Fernando Zegers-Hochschild, Chile
08:30 - 09:30
Session 39: The fallopian tube surgery in the era of ART
08:30 - 09:30: Session 39: The fallopian tube surgery in the era of ART:
María Isabel Acien, Spain
Kim Dreyer, The Netherlands
08:30 - 08:50
What is the role of tubal surgery in the era of ART?
09:00 - 09:20
How to evaluate the tubal function before and during surgery
Kamal Ojha, United Kingdom
08:30 - 09:30
Session 40: Poster discussion session - Ethics & Law
08:30 - 09:30: Session 40: Poster discussion session - Ethics & Law:
08:30 - 08:45
Redefining elective co-parenting: a systematic assessment of concepts and definitions found in the literature and a recommendation for new terminology
08:45 - 09:00
From cross-border reproduction to embryos and gametes transit: the peculiar italian case examined from ethical, legal, and comparative standpoint
09:00 - 09:15
Ready for polygenic risk scores? An analysis of regulation of preimplantation genetic testing in seven European countries
09:15 - 09:30
Identifying essential information for a valid informed consent (IC) of egg donors: An international Delphi study
09:30 - 10:00
Coffee break in the exhibit hall
09:30 - 10:00: Coffee break in the exhibit hall:
09:30 - 10:30
IBSA: A transatlantic perspectives to optimize ART results through hCG-driven LH activity
09:30 - 10:30: IBSA: A transatlantic perspectives to optimize ART results through hCG-driven LH activity:
Dominique De Ziegler, France
09:30 - 09:35
Welcome and introduction
Dominique De Ziegler, France
09:35 - 10:00
hCG-driven LH activity: rationale for a need and clinical options
Ernesto Bosch Aparicio, Spain
10:00 - 10:25
Does the timing of LH activity and the FSH/LH ratio matter?
10:25 - 10:30
Take home messages
Dominique De Ziegler, France
10:00 - 11:30
Session 41: Planet blastocyst
10:00 - 11:30: Session 41: Planet blastocyst:
Samantha Francina Huixian de Witte, The Netherlands
10:00 - 10:15
Blastocyst spent culture medium metabolite levels and reproductive outcomes
10:15 - 10:30
Blastocyst expansion speed assay: a putative artificial intelligence-powered tool for embryo selection. Retrospective study involving 2184 blastocysts and 786 PGT-A cycles
Federica Innocenti, Italy
10:30 - 10:45
Can embryo re-expansion pattern post-biopsy for PGT-A have a predictive value on the outcome?
Ibrahim Elkhatib, United Arab Emirates
10:45 - 11:00
Live birth of Day 7 blastocyst transfers. Another chance to succeed.
11:00 - 11:15
The spatial conformational features of blastocysts can serve as a new basis for selection
11:15 - 11:30
A novel approach to predicting the potential of a blastocyst using untargeted spectral analysis of spent culture medium and machine learning
Alexey Gryaznov, Russia C.I.S.
10:00 - 11:30
Session 42: (De)regulation of spermatogenesis process
10:00 - 11:30: Session 42: (De)regulation of spermatogenesis process:
Nicolás Garrido Puchalt, Spain
Andreas Meißner, The Netherlands
10:00 - 10:15
A systematic spatial HiPlex proteomics exploration of human testicular tissues from birth to adulthood
Shiyan Tang, United Kingdom
10:15 - 10:30
Retinoic acid has an essential role in meiotic progression beyond the zygotene stage in mouse testis
10:30 - 10:45
Down regulation of Clock gene in testicle may affect energy metabolism of sertoli cell
10:45 - 11:00
The consequences of paternal pre-conceptional health for offspring health and pregnancy outcomes: involvement of the germ-cell epigenome and non-germ cell factors
Raffaele Teperino, Germany
11:00 - 11:15
A comprehensive evaluation of spermatogenesis-related genes identifies novel common and rare risk loci for idiopathic severe spermatogenic failure
11:15 - 11:30
Functional characterisation of three human male infertility associated X-linked genes using Drosophila melanogaster as model organism
10:00 - 11:30
Session 44: Endometriosis, endometrial disorders and infertility: from bench to bedside
10:00 - 11:30: Session 44: Endometriosis, endometrial disorders and infertility: from bench to bedside:
Noortje Van Den Boogaard, The Netherlands
10:00 - 10:15
Serum Progesterone levels do not differ between patients with endometriosis and unaffected patients who conceive after Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) cycles
10:15 - 10:30
Role of serum progesterone levels and subcutaneous progesterone supplementation in endometriosis patients undergoing Artificial Cycle Frozen Embryo Transfer
Noémie Sachs-Guedj, Spain
10:30 - 10:45
Does presence of endometriosis adversely affect oocyte morphology? Evaluation of a large number of oocytes obtained from endometriosis patients, 27204 oocytes
10:45 - 11:00
The Endometriosis Longitudinal Fertility Study (ELFS): Outcomes for women with moderate or severe endometriosis who are trying to conceive
Vanessa Ross, United Kingdom
11:00 - 11:15
Identification and validation of RPL7 and RCCD1 as potential biomarkers associated with immune infiltration in patients with thin endometrium
11:15 - 11:30
Endometrial Preparation Using CONCEIVF Algorithm with Intrauterine and Sub-Endometrial Endosera Administration for Enhanced Pregnancy Rates in Women with Thin Endometrium
Dr Bharathi Rajanna, India
10:00 - 11:30
Session 45: Advancing clinical PGT-A: steps towards an evidence-based consensus
10:00 - 11:30: Session 45: Advancing clinical PGT-A: steps towards an evidence-based consensus:
Simone Broer, The Netherlands
10:00 - 10:15
Pre-implantation genetic testing for aneuploidies (PGT-A) improves reproductive outcomes in advanced maternal age patients undergoing IVF/ICSI: a multicentre retrospective cohort study with propensity score matching
Maria Flores Casteleiro Alves, Portugal
10:15 - 10:30
Clinical utility of preimplantation genetic testing for aneuploidy origin (PGT-AO) to enhance embryo selection for monogenic disorders: a retrospective pan-country integrative genomic and clinical study
Rick Essers, The Netherlands
10:30 - 10:45
Chromosomal, gestational, and neonatal outcomes of mosaic embryos: analysis of 3074 cases from the International Registry of Mosaic Embryo
Francesca Spinella, Italy
10:45 - 11:00
Limited utility of mosaicism reporting in PGT-A: independent confirmation from a European multisite, double-blinded analysis including 4293 embryo transfers following the first US experience.
Dhruti Babariya, United Kingdom
11:00 - 11:15
Trophectoderm biopsy for pre-implantation genetic testing (PGT) does not increase rates of placental abnormalities among singleton pregnancies conceived with in-vitro fertilization (IVF).
11:15 - 11:30
The effect of growth hormone on the euploid rate and morphokinetic signature of blastocysts in patients with advanced maternal age : a randomized controlled trial
10:00 - 11:30
Session 46: Socially and environmentally sustainable reproductive care
10:00 - 11:30: Session 46: Socially and environmentally sustainable reproductive care:
Denisa Marina Protopopescu, Romania
Taghride Dahhan, The Netherlands
10:00 - 10:15
Social disparities in achieving a live birth after initiating ART treatment: a national register-based study among women in Denmark.
10:15 - 10:30
Domestic and cross-border reproductive care among same-sex male intended parents: comparing live birth rates (LBRs) in a national retrospective cohort in the United States (U.S.)
10:30 - 10:45
Age at menarche is a marker for increased time to pregnancy
10:45 - 11:00
#Infertility: A systematic review of information available on social media platforms
Kugajeevan Vigneswaran, United Kingdom
11:00 - 11:15
Ethnic disparity in the use of treatment with assisted reproductive technologies in Denmark
Sofie Østergaard, Denmark
11:15 - 11:30
The effect of ambient exposure to air pollutants on live birth rates in frozen embryo transfer cycles.
Nikolaos P. Polyzos, Spain
10:00 - 11:30
Session 47: Poster discussion session - Reproductive endocrinology
10:00 - 11:30: Session 47: Poster discussion session - Reproductive endocrinology:
Samuel Dos Santos-Ribeiro, Portugal
10:00 - 10:15
Preselected for an award: A retrospective cohort study of the stability of ovarian reserve in women with Turner Syndrome (TS) and spontaneous menstruation
Zachary Nash, United Kingdom
10:15 - 10:30
Mild ovarian stimulation using the aromatase inhibitor letrozole (LTZ) is an effective stimulation protocol to obtain euploid blastocysts for women of an advanced maternal age
10:30 - 10:45
A randomized trial to compare the live birth rate following the progestin-primed ovarian stimulation versus the antagonist protocol in women with anticipated high ovarian responses
10:45 - 11:00
Association between PCOS phenotype-D and euploid blastocyst rate per cohort of inseminated oocytes: a matched case-control study versus idiopathic infertile women.
11:00 - 11:15
Prognostic statistical model of age-specific anti-Müllerian hormone (AMH) decrease based on hormone values of 23,528 women.
Martin Vladimirov, Bulgaria
11:15 - 11:30
Application of biomarkers in obese infertile women: a genetic tool for a personalized treatment
Charalampos Voros, Greece
11:15 - 12:15
Organon: Policy Solutions to Improve Access to Fertility Treatment and Optimise Patient Care
11:15 - 12:15: Organon: Policy Solutions to Improve Access to Fertility Treatment and Optimise Patient Care:
Hannah Armstrong, United Kingdom
11:45 - 13:00
Merck KGaA: Ageing and infertility: Overcoming the biological clock
11:45 - 13:00: Merck KGaA: Ageing and infertility: Overcoming the biological clock:
Frank J. Broekmans, The Netherlands
11:50 - 12:02
Global Fertility landscape
12:02 - 12:17
Ageing and infertility: unravelling the connections
12:17 - 12:47
Clinical insights: navigating age challenges in family building (speakers: Sunkara Sesh Kamal & Christos Venetis)
Co-speaker[0000788310] Clinical insights: navigating age challenges in family building
Sesh Kamal Sunkara, United Kingdom
Co-speaker[0000788310] Clinical insights: navigating age challenges in family building
12:47 - 12:55
It takes two to tango: the redemption of the sperm
12:55 - 13:00
Summary and conclusion remarks
11:45 - 12:45
Session 48: EU session: ESHRE & the EU: Navigating the new SoHO regulation and the EuMAR project
11:45 - 12:45: Session 48: EU session: ESHRE & the EU: Navigating the new SoHO regulation and the EuMAR project:
Carlos Calhaz-Jorge, Portugal
11:45 - 12:05
The New Regulation on Substances Of Human Origin (SoHO) (DG SANTE (European Commission)
Stefaan Van Der Spiegel, Belgium
12:05 - 12:15
Impact of the new SoHO regulation on ART practices
12:25 - 12:35
The road to a European prospective cycle-by-cycle data collection: EuMAR
Christian De Geyter, Switzerland
10:00 - 12:45
Session 43: Live surgery session - 20 years of live surgery
10:00 - 12:45: Session 43: Live surgery session - 20 years of live surgery:
Michelle Nisolle, Belgium
Transvaginal endoscopy: Hysteroscopy & Laparoscopy(THL)
Attilio Di Spiezio Sardo, Italy
Stavros Karampelas, Greece
Helena Van Kerrebroeck, Belgium
Filipa Beja Osorio, Portugal
11:45 - 12:45
Session 49: Stem cells in reproductive medicine: from basic science to clinical applications
11:45 - 12:45: Session 49: Stem cells in reproductive medicine: from basic science to clinical applications:
Jan-Bernd Stukenborg, Sweden
Ans van Pelt, The Netherlands
11:45 - 12:05
Modelling early human development and implantation using stem cells
12:15 - 12:35
The therapeutic potential of stem cells for ovarian rejuvenation
11:45 - 12:45
Session 50: Third-party reproduction - how will the paradigm change counselling?
11:45 - 12:45: Session 50: Third-party reproduction - how will the paradigm change counselling?:
Monique H. Mochtar, The Netherlands
11:45 - 12:05
Advances in oocyte freezing: implications for donors, recipients, counsellors and clinics
Nicky Hudson, United Kingdom
12:15 - 12:35
The next generation of adolescents will consider more and more multiparenthood, poliparenthood
11:45 - 12:15
Session 51: FSANZ Exchange session
11:45 - 12:15: Session 51: FSANZ Exchange session:
Gijs Teklenburg, The Netherlands
11:45 - 12:05
Apicobasal RNA asymmetries regulate cell fate in the early mouse embryo
11:45 - 12:45
Session 52: Poster discussion session - Reproductive genetics
11:45 - 12:45: Session 52: Poster discussion session - Reproductive genetics:
Alberto Sola-Leyva, Sweden
11:45 - 12:00
Preselected for an award: Characterization of the morphology of the outer-kinetochore expandable module, aka fibrous corona, and its role in ensuring proper chromosome segregation in human and bovine oocytes
Chiara Baggio, The Netherlands
12:00 - 12:15
Chaotic blastocysts in preimplantation genetic testing for aneuploidies: prevalence, characterization and re-biopsy results
12:15 - 12:30
Application of simultaneous PGT-M/PGT-A using whole genome sequencing and haplotyping for monogenetic disorders, multiple variants, low penetrance, and de novo disorders
Svetlana Madjunkova, Canada
12:30 - 12:45
Decoding ovarian response: the predictive power of FSH receptor gene expression in controlled ovarian stimulation
Zeynep Gunes, United Kingdom
13:00 - 14:00
Lunch break in the exhibit hall
13:00 - 14:00: Lunch break in the exhibit hall:
14:00 - 15:15
Gedeon Richter: Comprehensive Insights into Endometriosis: Epidemiology, Mechanisms of action and Modern Therapies
14:00 - 15:15: Gedeon Richter: Comprehensive Insights into Endometriosis: Epidemiology, Mechanisms of action and Modern Therapies:
Bart C.J.M. Fauser, The Netherlands
14:00 - 14:25
In-depth Look at the Epidemiology of Endometriosis
14:25 - 14:50
Decoding Endometriosis Mechanisms and their Impact on Fertility
Edgardo Somigliana, Italy
14:50 - 15:15
A Dive into Contemporary Treatments for Endometriosis with Real-Life Clinical Cases
14:00 - 15:00
Session 53: MHR symposium: Basic principles of human development revealed by natural embryos and stem cell-generated embryo models
14:00 - 15:00: Session 53: MHR symposium: Basic principles of human development revealed by natural embryos and stem cell-generated embryo models:
14:00 - 14:20
Live imaging reveals key events in preimplantation embryo development
14:30 - 14:50
Gastruloids: a pluripotent stem cell model of gastrulation and body plan engineering in development and disease
Alfonso Martinez-Arias, United Kingdom
14:00 - 15:00
Session 54: Sustainability in the ART lab - essential, but is it feasible?
14:00 - 15:00: Session 54: Sustainability in the ART lab - essential, but is it feasible?:
Maria Jose De Los Santos, Spain
Marjoleine Louwerse, The Netherlands
14:00 - 14:20
Marginal gains: can small actions in the ART lab improve the environmental impact of medically assisted reproduction?
Francesca Farlie, United Kingdom
14:30 - 14:50
Ethical practices and policies for ART carbon reduction
Cristina Richie, United Kingdom
14:00 - 15:00
Session 55: Pregnancy loss: the emotional toll for parents and providers
14:00 - 15:00: Session 55: Pregnancy loss: the emotional toll for parents and providers:
Karen Henriette Kirchheiner Jensen, Denmark
Marie-Louise van der Hoorn, The Netherlands
14:00 - 14:20
Hoping for the best, expecting the worst: pregnancy after loss
Jacky Boivin, United Kingdom
14:30 - 14:50
Emotional experiences of staff caring for parents suffering a pregnancy loss
Johnson Judith, United Kingdom
15:00 - 15:10
Empowering excellence: Elevating Fertility Nursing Practice through ESHRE’s Certification.
Valerie Peddie, United Kingdom
14:00 - 15:00
Session 56: Patient session: Donation: a 360° view
14:00 - 15:00: Session 56: Patient session: Donation: a 360° view:
Monika Bulmanska-Wingett, United Kingdom
14:00 - 14:15
From secrecy to transparency: The journey of donor identity in reproductive medicine in Portugal
14:20 - 14:35
On being whole – fantasy and the unthought known
14:40 - 14:55
It takes more than genes to build a family
Maciej Śmiechowski, Poland
14:00 - 15:00
Session 57: To err is human: building a safer fertility clinic
14:00 - 15:00: Session 57: To err is human: building a safer fertility clinic:
14:00 - 14:20
To err is human, also for those working in ART
14:30 - 14:50
Building a safer fertility clinic
14:00 - 15:00
Session 58: Poster discussion session - GSCAIF
14:00 - 15:00: Session 58: Poster discussion session - GSCAIF:
Miray Nilufer Cimsit Kemahli, Turkey
14:00 - 14:15
Prevalence of chromosomal abnormalities in oocyte donor candidates: a French survey of over 8200 karyotypes
14:15 - 14:30
Egg-conomized frozen embryo transfer
Pluk Korsen, The Netherlands
14:30 - 14:45
Proposal of model to calculate the trend in the cumulative live birth rate in IVF cycles using Spanish National Register data from 2009 to 2021
Rocio Nunez - Calonge, Spain
14:45 - 15:00
Risk of placenta previa in assisted reproduction: population study with sibling analyses from the committee of nordic ART and safety
14:45 - 15:45
Besins Healthcare: Unravelling the "Black Box" in Luteal Phase Support
14:45 - 15:45: Besins Healthcare: Unravelling the "Black Box" in Luteal Phase Support:
Frank J. Broekmans, The Netherlands
14:45 - 15:00
Introduction by the Chairmen
15:00 - 15:15
State of the Art in Luteal Phase Support
15:15 - 15:30
Natural Proliferative Phase: A New Era in FET Cycles
Samuel Dos Santos-Ribeiro, Portugal
15:30 - 15:45
Questions and Conclusions by the Chairmen
15:15 - 16:30
Session 59: Can insemination techniques be improved?
15:15 - 16:30: Session 59: Can insemination techniques be improved?:
Kaylee Holleman, The Netherlands
15:15 - 15:30
Piezo-ICSI reduces oocyte degeneration, improves ICSI success rates and has shown less dependence on the experience level of embryologists: cumulative data with 65,033 MII oocytes
15:30 - 15:45
Far away so close: remote ICSI using an AI-powered robot
Gerardo Mendizabal, Mexico
15:45 - 16:00
A novel micro-insemination method, assisted sperm fusion insemination, increases the embryo utilization rate compared to conventional intracytoplasmic sperm injection
16:00 - 16:15
Real-word data on effectiveness of ICSI over conventional IVF according to infertility factors based on Human Fertilisation and Embryology Authority dataset.
16:15 - 16:30
Conventional in vitro fertilisation versus intracytoplasmic sperm injection in first cycle patients without severe male factor infertility (INVICSI): a randomised, controlled, open-label, multicentre trial
15:15 - 16:30
Session 60: Rethinking PCOS
15:15 - 16:30: Session 60: Rethinking PCOS:
Jan-Peter de Bruin, The Netherlands
15:15 - 15:30
Letrozole-resistant PCOS: prevalence, further options and course of fertility treatment
15:30 - 15:45
Hormone-free versus FSH-primed infertility treatment of women with polycystic ovary syndrome using biphasic in vitro maturation: a randomised clinical trial
15:45 - 16:00
Delayed fetal growth in pregnant women with polycystic ovary syndrome using serial ultrasonographic biometry
16:00 - 16:15
Kisspeptin as a test of hypothalamic function in women presenting with oligo-amenorrhea
Arthur Yeung, United Kingdom
16:15 - 16:30
Age-related normograms of AMH in women with polycystic ovary syndrome using three different assays
FEDERICA BARBAGALLO, Italy
15:15 - 16:30
Session 61: Sperm quality and ART outcomes
15:15 - 16:30: Session 61: Sperm quality and ART outcomes:
Sandra Tanahatoe, The Netherlands
15:15 - 15:30
Cumulative live birth and neonatal outcomes according to different male factors in IVF/ICSI cycles
15:30 - 15:45
Decreased embryo developmental potential and lower cumulative pregnancy rate in males with multiple morphological abnormalities of the sperm flagella
15:45 - 16:00
Men who fathered embryos with poor pre-implantation development rates exhibit an increased frequency of sperm with high DNA accessibility
Mark E. Gill, Switzerland
16:00 - 16:15
Correlation of intracellular pH of non-normozoospermic men with fertilization rates in assisted reproduction procedures (Pilot study)
Gabriela Carrasquel Martínez, Mexico
16:15 - 16:30
The decline in semen quality parameters enhances mosaicism in trophectoderm biopsy of human blastocysts
Davaakhuu Sengebaljir, Mongolia
15:15 - 16:30
Session 62: Advancements in implantation and early pregnancy
15:15 - 16:30: Session 62: Advancements in implantation and early pregnancy:
Annemarie G.M.G.J. Mulders, The Netherlands
15:15 - 15:30
IVF Success Rates: Challenging the Concept of Recurrent Implantation Failure
15:30 - 15:45
Association between proton pump inhibitors use and the risk of maternal infections during pregnancy and postpartum: A Swedish population-based cohort study
15:45 - 16:00
Antinuclear antibodies in women with recurrent early pregnancy loss: prevalence and impact on subsequent pregnancy outcome
16:00 - 16:15
Novel use of Hyaluronan Enriched Media for Improving Implantation in Intrauterine Insemination: A Prospective Randomised Controlled Trial (HEMI Trial)
Navdeep Kaur Ghuman, India
16:15 - 16:30
Comparing viable and non-viable IVF early pregnancy measurements: Does knowledge of gestational age using date of et potentially change miscarriage diagnosis guidelines in IVF patients
Sughashini Murugesu, United Kingdom
15:15 - 16:30
Session 63: Endometrial support strategies - what do the studies say?
15:15 - 16:30: Session 63: Endometrial support strategies - what do the studies say?:
Baris Ata, United Arab Emirates
Femi Janse, The Netherlands
15:15 - 15:30
Optimal timing and endometrial preparation in modified natural cycle (mNC) frozen embryo transfer (FET) cycles: The FET OPTIMIZING randomised controlled trial
15:30 - 15:45
Dydrogesterone versus micronized vaginal progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer cycles (REMODEL): an exploratory randomized controlled trial.
Caroline Roelens, Belgium
15:45 - 16:00
Natural, modified natural or artificial endometrial preparation strategies for frozen embryo transfer in ovulatory women (MONART): a randomized controlled trial
16:00 - 16:15
Comparison of the pregnancy outcomes of transferring frozen embryos versus fresh embryos among advanced maternal age women: A nationwide analysis of 232,942 cycles
16:15 - 16:30
The Programmed Ovulatory Frozen-Thawed Embryo Transfer Cycle (PO-FET): a suggested FET protocol integrating aspects of embryo transfer scheduling, efficacy optimization and maternal/fetal safety
Tanja K. Eggersmann, Germany
15:15 - 16:30
Session 64: Safety and quality from embryo to offspring
15:15 - 16:30: Session 64: Safety and quality from embryo to offspring:
Aleksej Stevanovic, Norway
15:15 - 15:30
Identifying toxicity trends: analysis of over 6700 Mouse Embryo Assays performed on 16 categories of IVF supplies
Albert Martínez-Casado, Spain
15:30 - 15:45
DNA methylation signature of monozygotic twinning: investigating the relationship with medically assisted reproduction, higher-order gestations, and common genetic variants
Jenny Van Dongen, The Netherlands
15:45 - 16:00
Exploring risk factors of mismatch in the ART laboratory: An analysis based on 73719 electronic witnessing points
16:00 - 16:15
A need to standardize: The use and posterior recall of toxic consumables could be avoided with the appropriate testing protocols
16:15 - 16:30
Analysis of risk factors for monozygotic twins following in vitro fertilization-embryo transfer
15:15 - 16:30
Session 65: Poster discussion session - Embryology
15:15 - 16:30: Session 65: Poster discussion session - Embryology:
Sofia Makieva, Switzerland
15:15 - 15:30
Preselected for an award: Deep sequencing of spermatozoal accessible chromatin reveals complex arrangements underlying spermatozoal chromatin packaging and fertilization
David Iles, United Kingdom
15:27 - 15:39
Early blastocyst formation on day 4 is associated with improved clinical outcome and advocates for embryo quailty assessment on day 4.
15:40 - 15:52
Structural changes of the human sperm tail during the early post-fertilization
15:52 - 16:04
Image-based oocyte model predictive of blastocyst development correlates with ploidy status across a broad spectrum of PGT-A indications, accounting for confounding variables
16:05 - 16:17
Does assessment of time-lapse videos result in improved prediction of clinical pregnancy compared to assessment of single images of blastocysts?
16:17 - 16:29
Number of autologous mature oocytes as a predictor of live birth rate in women aged over 40 who do not accept egg donation
Maria Pia Zappacosta Villarroel, Argentina
16:30 - 17:00
Coffee break in the exhibit hall
16:30 - 17:00: Coffee break in the exhibit hall:
16:45 - 18:00
Organon LLC: Meeting the needs of your patients: The right approaches in the clinic and the lab to deliver the results desired.
16:45 - 18:00: Organon LLC: Meeting the needs of your patients: The right approaches in the clinic and the lab to deliver the results desired.:
Lecture The Clinical Approach
Juan A. Garcia-Velasco, Spain
17:00 - 18:00
Session 66: Unraveling the influence: external factors impacting outcomes
17:00 - 18:00: Session 66: Unraveling the influence: external factors impacting outcomes:
Koen van Zomeren, The Netherlands
17:00 - 17:15
The Effect of Constant 5% Versus Gradient 8%, 5%, 2% Oxygen Concentration on the Development of Sibling Human Embryos in Vitro to the Blastocyst Stage
Peter Slatinsek, Slovenia
17:15 - 17:30
Copper oxide nanoparticles (CuONPs) impairs mitophagy and promotes DNA methylation to suppress mouse embryonic pluripotency
17:30 - 17:45
The impact of maternal age on cumulative life birth rates after single euploid embryo transfer: differences between autologous and donor oocyte cycles
17:45 - 18:00
Evaluating the impact of obesity on oocyte quality, using 2 main factors in cumulus cells (CC) and follicular fluid (FF) which reflect oocyte quality
17:00 - 18:00
Session 67: Artificial intelligence - the state of the ART
17:00 - 18:00: Session 67: Artificial intelligence - the state of the ART:
Tjitske Zaat, The Netherlands
17:00 - 17:15
Prospective validation of an artificial intelligence platform for automated follicle counting
17:15 - 17:30
Explainable artificial intelligence (XAI) to determine the follicle sizes on trigger day that maximize mature oocyte yield
Simon Hanassab, United Kingdom
17:30 - 17:45
Ovarify: a deep learning model for automatic calculation of ovarian morphological features in pelvic ultrasonography
17:45 - 18:00
An interpretable deep learning model for predicting the number of mature oocytes retrieved after ovarian hyperstimulation
17:00 - 18:00
Session 68: Third party reproduction: from decision to disclosure
17:00 - 18:00: Session 68: Third party reproduction: from decision to disclosure:
Mariana Moura-Ramos, Portugal
Marieke Schoonenberg, The Netherlands
17:00 - 17:15
The impact of psychological counselling on decision-making of sperm donation among the couples with nonobstructive azoospermia after unsuccessful microdissection testicular sperm extraction
17:15 - 17:30
Can the theory of planned behavior predict parents’ disclosure of donor conception to their children within 5-9 years?
17:30 - 17:45
"There might be two hundreds of us" - A qualitative study on the experience of meeting large numbers of same donor offspring
17:45 - 18:00
A study investigating whether egg share donors treatment outcome impacted on their overall psychological well-being and treatment experience
Tim Bracewell-Milnes, United Kingdom
17:00 - 18:00
Session 69: Reproductive surgery
17:00 - 18:00: Session 69: Reproductive surgery:
Judith Rikken, The Netherlands
17:00 - 17:15
Effects of preventive uterine artery occlusion during laparoscopic myomectomy on ovarian reserve markers: a randomized controlled trial.
Isabelle Streuli, Switzerland
17:15 - 17:30
First successful ovary allotransplants to Turner’s syndrome patients requiring immunosuppression
Sherman J. Silber, U.S.A.
17:30 - 17:45
Do myomectomies decrease third trimester pregnancy complications when compared to women without myomectomies and uterine fibroids in situ? A study of an American population database.
17:45 - 18:00
Neck scarf of ureter and Intraoperative ICG-fluorescence for preventing ureters injuries in Da Vinci Robotic deep infiltrating endometriosis excision.
Yi-Chen Chuang, Taiwan R.O.C.
17:00 - 18:00
Session 70: Ethics, information, and choice in medically assisted reproduction
17:00 - 18:00: Session 70: Ethics, information, and choice in medically assisted reproduction:
Nicola Williams, United Kingdom
Ana Pereira Daoud, The Netherlands
17:00 - 17:15
The ethics of disclosing reported conditions in donor-conceived offspring to recipients of the same donor
17:15 - 17:30
Offering and regulating expanded carrier screening (ECS) in the UK: an exciting prospect in genetic testing or ‘a can of worms’?
Cathy Herbrand, United Kingdom
17:30 - 17:45
New principles for the use of artificial intelligence in human reproduction: leave everything as it is?
Michiel De Proost, Belgium
17:45 - 18:00
The current landscape for carrier screening in donor conception; a game of chance for donors and recipients?
Colleen Lynch, United Kingdom
17:00 - 18:00
Session 71: Poster discussion session - Endometriosis & endometrial disorders
17:00 - 18:00: Session 71: Poster discussion session - Endometriosis & endometrial disorders:
17:00 - 17:15
Relugolix combination therapy vs relugolix monotherapy with transition to relugolix combination therapy for the treatment of endometriosis-associated pain: implications for cumulative benefit/risk profile
Christian Becker, United Kingdom
17:15 - 17:30
Finding on the gut microbiome impact on non-reproductive pathologies of the uterus: an endometriosis perspective
Alejandro De Tena Sanz, Spain
17:30 - 17:45
Enhancing endometrial thickness and implantation rates: a study on the effectiveness of autologous blood cell derivative - endosera in infertile women with thin endometrium
vasanthi Palanivel, India
17:45 - 18:00
Spatial transcriptomics identifies dysregulated pathways in adenomyosis proposing potential re-purposed lesion-specific treatments
Alison Maclean, United Kingdom
18:00 - 19:00
Annual General Assembly of Members
18:00 - 19:00: Annual General Assembly of Members:
13:00 - 14:00
SIG Nurses and Midwives members' meeting
13:00 - 14:00: SIG Nurses and Midwives members' meeting:
09:00 - 11:00
Fertility Europe meeting
09:00 - 11:00: Fertility Europe meeting:
09:00 - 11:00
WG on Good practice for IVF labs
09:00 - 11:00: WG on Good practice for IVF labs:
10:00 - 10:30
CSAO/FSANZ Award Committee meeting
10:00 - 10:30: CSAO/FSANZ Award Committee meeting:
11:00 - 12:00
ESHRE-CSRM meeting
11:00 - 12:00: ESHRE-CSRM meeting:
11:00 - 13:30
NMCC Committee meeting Part 2
11:00 - 13:30: NMCC Committee meeting Part 2:
11:30 - 14:00
FeRGI meeting
11:30 - 14:00: FeRGI meeting:
12:00 - 14:00
Human Reproduction Update Associate Editors' meeting
12:00 - 14:00: Human Reproduction Update Associate Editors' meeting:
12:00 - 14:00
Human Reproduction Open Associate Editors' meeting
12:00 - 14:00: Human Reproduction Open Associate Editors' meeting:
13:00 - 14:00
ESHRE/ASRM Liaison Committee meeting
13:00 - 14:00: ESHRE/ASRM Liaison Committee meeting:
13:00 - 14:00
Ethics Committee meeting
13:00 - 14:00: Ethics Committee meeting:
13:00 - 14:00
SIG Reproductive Genetics Steering Committee Meeting
13:00 - 14:00: SIG Reproductive Genetics Steering Committee Meeting:
13:00 - 14:00
Women's Health Research Centre meeting
13:00 - 14:00: Women's Health Research Centre meeting:
13:00 - 14:00
BSAO Award Committee meeting
13:00 - 14:00: BSAO Award Committee meeting:
13:00 - 15:00
ECRES Committee meeting
13:00 - 15:00: ECRES Committee meeting:
13:00 - 16:00
EIM Consortium General Assembly meeting
13:00 - 16:00: EIM Consortium General Assembly meeting:
13:00 - 18:00
Cochrane meeting
13:00 - 18:00: Cochrane meeting:
14:00 - 15:00
ESHRE-REDLARA meeting
14:00 - 15:00: ESHRE-REDLARA meeting:
15:00 - 16:00
Nurses Award Committee meeting
15:00 - 16:00: Nurses Award Committee meeting:
15:00 - 17:00
Adenomyosis working group meeting
15:00 - 17:00: Adenomyosis working group meeting:
15:30 - 18:00
Fertility Europe meeting
15:30 - 18:00: Fertility Europe meeting:
16:30 - 17:00
BSAP Award Committee meeting
16:30 - 17:00: BSAP Award Committee meeting:
16:30 - 17:00
CSAP Award Committee meeting
16:30 - 17:00: CSAP Award Committee meeting:
16:30 - 17:15
Vitrolife Group & ESHRE Chairs meeting
16:30 - 17:15: Vitrolife Group & ESHRE Chairs meeting:
17:00 - 19:00
Pre-conception care kick-off meeting
17:00 - 19:00: Pre-conception care kick-off meeting: